Women who intentionally lost five per cent or more of their body weight had 29 per cent lower risk of developing endometrial cancer during the study.
Postmenopausal women who intentionally lost weight over the course of three years had a much lower risk of endometrial cancer up to 11 years later compared to women whose weight didn’t change, a US study finds.
Overall, women who intentionally lost five per cent or more of their body weight had 29 per cent lower risk of developing endometrial cancer during the study period, and the effect was most pronounced for obese women, whose risk dropped by 66 per cent with weight loss.
“We decided to do the study because we realised that, although obesity increases the risk of endometrial cancer, research couldn’t say if intentional weight loss, especially among older persons, could reduce that risk,” said lead author Juhua Luo, School of Public Health at Indiana University in Bloomington.
Denne historien er fra March 16, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra March 16, 2017-utgaven av Express Pharma.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Driving pharma efficiency with Körber's Ecosystem solutions
Körber streamlines pharmaceutical manufacturing with a comprehensive ecosystem of advanced and connected solutions. Their guiding principle is simple: Everything, effortlessly, in one place. With top-tier solutions spanning cutting-edge machinery, packaging, materials, software, and expert guidance, Körber propels clients towards establishing their Factory of Excellence, optimizing every process for efficiency and safety, inform Rajesh Vedak President Körber India, Körber Business Area Pharma.
Customer satisfaction and innovation drive JULABO's growth in global temperature control markets
Markus Juchheim, Managing Director of JULABO GmbH, shares insights with Express Pharma on the company's strategies for innovation, regulatory compliance, and customer-focused growth in the evolving temperature control technology market.
From lab to plant: Process safety data sheets as the key to safe scale-up
Mario Toubes-Rodrigo, Global Applications Leader, H.E.L Group highlights that process safety testing is essential in API manufacturing to safely scale production from lab to industrial levels. Advanced techniques help identify and mitigate hazards, ensuring safe, compliant, and efficient processes
Eco-conscious packaging: A strategic opportunity
Larger pharma companies are applying sustainable practices and eco-conscious materials to packaging and labelling, leading to positive environmental outcomes, increasing operational efficiency and improving consumer perception. But wooing environmentally-conscious consumers often needs a sizeable capex, which could be a hurdle for pharma MSMEs. Viveka Roychowdhury reports that MSMEs can maximise this strategic opportunity once they identify areas which can improve efficiency through optimisation and harmonisation, at reasonable costs
ACG covers every facet of the pharma process, all under one roof and seamlessly interconnected
ACG Inspection's Life Sciences Cloud will be making its India debut at the CPhI India- PMec India 2024 show. Udit Singh, CEO, ACG Inspection spoke to Viveka Roychowdhury on its USPs, highlighting its modular nature, the zero cost of transition from existing systems, and the advantage of ACG's long term partnerships with global standard setting organisations like GS1 which allow its platforms to deliver regulatory compliance deliverables in advance
We, at OmniActive, invest over 10 per cent of the total outlay into R&D
Sanjaya Mariwala, Executive Chairman and MD, OmniActive Health Technologies shares insights into the company's significant investments in R&D, advanced testing capabilities, and strategies for optimising bioactive ingredients. He also discusses the impact of regulatory changes, quality assurance, and consumer education in the evolving nutraceutical landscape, in an interview with Viveka Roychowdhury
Save coating time, boost production efficiency
Instacoat 4G unique formulation includes an optimal ratio of polymer, plasticizer, and pigments, ensuring a smooth, uniform coating while significantly reducing preparation and process time
Pharma companies can optimise R&D budgets using advanced technologies
Pharma companies can optimise their R&D budgets to maximise innovation and deliver high-value therapies by using combination of new technologies to enhance innovation, feed the drug-development pipeline and speed to market.
The wide-ranging health benefits of Pycnogenol for women of all ages
Dr Franziska Weichmann, Manager of Scientific Communications and Product Development at Horphag Research, highlights benefits of Pycnogenol, a French maritime pine bark extract, offering women across all life stages a natural way to manage the physical and emotional challenges tied to hormonal changes
Indian pharma industry: Urgent need for action in the manufacturing sector
Dr Ajay Babu Pazhayattil, President of cGMPWorld, offers invaluable insights from FDA Form 483 observations issued to Indian pharma facilities, shedding light on the industry's critical challenges today. His analysis provides immediate and practical plans to minimise regulatory compliance risks. These measures will help reinforce the Indian industry's commitment to supplying the much-needed lifesaving drug products for the regulated US market
